INDEPENDENT NEWS

PHARMAC appeal ontreatment for ultra-rare blood disease

Published: Thu 24 Jan 2013 11:59 AM
New Zealanders rallying PHARMAC for life-saving treatment for ultra-rare blood disease
Eight Kiwis battling an ultra-rare blood disease that claims the lives of one-in-three patients within five years of diagnosis, if untreated, will be appealing to PHARMAC this Thursday, January 24, to save their lives.
A life-saving treatment renowned for its powerful reversal of disease progression, is available under funding arrangements in more than 40 countries world-wide.
Yet New Zealand remains an anomaly – the only country in the advanced OECD not funding the treatment for its citizens.
If these Kiwis don’t get access to this treatment, they will die. It’s simply a matter of time.
Their only hope for survival rests in the hands of NZ government medicines-funding agency, PHARMAC.
To learn more about their plight and petition for life, speak to the following people:
ENDS
Download full media kit THURS, JAN 24 @ www.pnhsanz.org.nz/media

Next in Lifestyle

Malicious Melodrama - Todd Haynes’ ‘May December’
By: Howard Davis
The Austerity Of Quiet Despair - Wim Wenders’ ‘Perfect Days’
By: Howard Davis
View as: DESKTOP | MOBILE © Scoop Media